GSA Capital Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $474K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $548K | Buy |
|
|||||
|
2024
Q2 | $205K | Sell |
|
|||||
|
2024
Q1 | $296K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.23M | Buy |
|
|||||
|
2023
Q2 | $520K | Sell |
|
|||||
|
2023
Q1 | $897K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $312K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $724K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $327K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $156K | Sell |
|
|||||
|
2018
Q3 | $573K | Buy |
|
|||||
|
2018
Q2 | $322K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $2.63M | Buy |
|
|||||
|
2015
Q1 | $1.54M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $213K | Sell |
|
|||||
|
2013
Q4 | $823K | Sell |
|
|||||
|
2013
Q3 | $1.93M | Buy |
|
|||||
|
2013
Q2 | $848K | Buy |
|